Discover
JAGX
Jaguar Health, Inc.
2.71
2 x 0.22
1 x 3.20
bid
ask
-
0.04
1.45%
2 @ 07:59 PM
2.71 +0.00 (0.00%)
| Ytd | -99.45% | |
| 1y | -99.73% |
2.65
day range
3.16
2.71
52 week range
1223.25
| Open | 2.76 | Prev Close | 2.75 | Low | 2.65 | High | 3.16 | Mkt Cap | 1.18M |
| Vol | 234.00K | Avg Vol | 24.90K | EPS | 1473.00 | P/E | 0.00 | Forward P/E | -0.37 |
| Beta | 0.88 | Short Ratio | 1.12 | Inst. Own | 1.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 14.52 | 200-d Avg | 208.47 | 1yr Est | 6.00 |
| Income Statement | |||
| Total Revenue | 1.23M | ||
| Revenues (USD) | 1.23M | ||
| Cost of Revenue | 1.03M | ||
| Gross Profit | 194.00K | ||
| Operating Expenses | 7.79M | ||
| Research and Development Expense | 3.34M | ||
| Selling, General and Administrative Expense | 4.46M | ||
| Operating Income | -7.60M | ||
| Interest Expense | 161.00K | ||
| Net Income | -12.68M | ||
| Net Income Common Stock | -12.70M | ||
| Net Income Common Stock (USD) | -12.70M | ||
| Consolidated Income | -12.80M | ||
| Net Income to Non-Controlling Interests | -120.00K | ||
| Earnings per Basic Share | -236.00 | ||
| Earnings per Basic Share (USD) | -236.00 | ||
| Earnings per Diluted Share | -236.00 | ||
| Earning Before Interest & Taxes (EBIT) | -12.52M | ||
| Earning Before Interest & Taxes (USD) | -12.52M | ||
| Preferred Dividends Income Statement Impact | 19.00K | ||
| Weighted Average Shares | 53.94K | ||
| Weighted Average Shares Diluted | 53.94K | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.59M | ||
| Cash and Equivalents (USD) | 6.59M | ||
| Trade and Non-Trade Receivables | 198.00K | ||
| Current Assets | 17.53M | ||
| Property, Plant & Equipment Net | 1.43M | ||
| Total Assets | 34.19M | ||
| Debt Current | 14.05M | ||
| Total Debt | 16.65M | ||
| Current Liabilities | 25.38M | ||
| Debt Non-Current | 2.60M | ||
| Total Liabilities | 29.27M | ||
| Accumulated Retained Earnings (Deficit) | -403.75M | ||
| Accumulated Other Comprehensive Income | -1.24M | ||
| Shareholders Equity | 6.62M | ||
| Shareholders Equity (USD) | 6.62M | ||
| Assets Non-Current | 16.66M | ||
| Total Debt (USD) | 16.65M | ||
| Deferred Revenue | 468.00K | ||
| Goodwill and Intangible Assets | 15.09M | ||
| Inventory | 7.32M | ||
| Liabilities Non-Current | 3.89M | ||
| Trade and Non-Trade Payables | 4.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 542.00K | ||
| Net Cash Flow from Financing | 1.86M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.47M | ||
| Issuance (Repayment) of Debt Securities | -118.00K | ||
| Net Cash Flow from Operations | -5.34M | ||
| Effect of Exchange Rate Changes on Cash | 2.00K | ||
| Share Based Compensation | 171.00K | ||